News Releases

This information is part of the archives and is no longer current and may no longer be accurate.

Keyword Search
 
2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010
DateTitle 
Nov 07, 2011DURECT Corporation to Participate in Upcoming Healthcare ConferencesPrinter Friendly Version
Nov 03, 2011DURECT Corporation Announces Third Quarter 2011 Financial Results and Update of ProgramsPrinter Friendly Version
Oct 26, 2011DURECT Corporation Invites You to Join its Third Quarter 2011 Earnings Conference CallPrinter Friendly Version
Sep 06, 2011DURECT Completes Enrollment in Pivotal U.S. Phase III Trial for POSIDUR® (BESST)Printer Friendly Version
Aug 31, 2011DURECT Corporation to Participate in Upcoming Healthcare ConferencesPrinter Friendly Version
Aug 04, 2011DURECT Corporation Announces Second Quarter 2011 Financial Results and Update of ProgramsPrinter Friendly Version
Jul 28, 2011DURECT Corporation Invites You to Join its Second Quarter 2011 Earnings Conference CallPrinter Friendly Version
Jul 12, 2011Zogenix and DURECT Announce Development and License Agreement for Antipsychotic Product CandidatePrinter Friendly Version
Jun 24, 2011Pfizer Receives Complete Response Letter from FDA for REMOXY®Printer Friendly Version
Jun 03, 2011DURECT to Present at the Jefferies Healthcare ConferencePrinter Friendly Version
Jun 02, 2011DURECT Announces Resignation of Chief Medical OfficerPrinter Friendly Version
May 12, 2011DURECT to Present at the UBS Global Specialty Pharmaceuticals ConferencePrinter Friendly Version
May 05, 2011DURECT Corporation Announces First Quarter 2011 Financial Results and Update of ProgramsPrinter Friendly Version
Apr 28, 2011DURECT Corporation Invites You to Join its First Quarter 2011 Earnings Conference CallPrinter Friendly Version
Apr 11, 2011DURECT Announces ELADUR(R) (TRANSDUR(R)-Bupivacaine) Phase II Study Results in Chronic Low Back PainPrinter Friendly Version
Mar 02, 2011DURECT Corporation Announces Fourth Quarter and Year End 2010 Financial ResultsPrinter Friendly Version
Mar 01, 2011DURECT to Present at Cowen and Company Health Care ConferencePrinter Friendly Version
Feb 24, 2011DURECT Corporation Invites You to Join its Fourth Quarter 2010 Earnings Conference CallPrinter Friendly Version
Feb 09, 2011DURECT Reports Data From European Phase IIb Shoulder Study of POSIDUR(TM) (SABER(TM)-Bupivacaine) and Amendment of the Nycomed AgreementPrinter Friendly Version
Feb 08, 2011DURECT Announces Launch of First FDA Approved SABER(TM)-Injectable Peptide ProductPrinter Friendly Version
Feb 07, 2011DURECT to Present at the BIO CEO & Investor ConferencePrinter Friendly Version
Jan 27, 2011REMOXY(R) New Drug Application Accepted by the FDA with PDUFA Goal Date of June 23, 2011Printer Friendly Version